Meeting
2018 ASCO Annual Meeting
Symptom burden and employment status in breast cancer (BC) survivors.
Authors
Ines Maria Vaz Duarte Luis
Dana-Farber Cancer Institute, Boston, MA
Ines Maria Vaz Duarte Luis , Anne M. O'Neill , Karen Sepucha , Kathy D. Miller , Chau T. Dang , Donald W. Northfelt , Eric P. Winer , George W. Sledge Jr., Bryan P. Schneider , Ann Partridge
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Patient and Survivor Care
Track
Patient and Survivor Care
Sub Track
Late and Long-Term Effects
Clinical Trial Registration Number
NCT00433511
Citation
J Clin Oncol 36, 2018 (suppl; abstr 10073)
DOI
10.1200/JCO.2018.36.15_suppl.10073
Abstract #
10073
Poster Bd #
61
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Inflammatory cytokines and distant recurrence in HER2-negative early breast cancer in the ECOG-ACRIN 5103 trial.
First Author: Joseph A. Sparano
Poster
2018 ASCO Annual Meeting
Immune profiling of pre- and post-treatment breast cancer tissues from the S0800 randomized neoadjuvant trial of weekly nab-paclitaxel with or without bevacizumab and dose dense doxorubicin and cyclophosphamide.
First Author: Xiaotong Li
Poster
2017 ASCO Annual Meeting
SWOG S0221 updated: Randomized comparison of chemotherapy schedules in breast cancer adjuvant therapy.
First Author: G. Thomas Budd
Poster
2013 ASCO Annual Meeting
A multicenter audit of the incidence of febrile neutropenia and neutropenia associated with docetaxel and cyclophosphamide (TC) chemotherapy for early breast cancer.
First Author: Roopa Lakhanpal